BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19792049)

  • 1. Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry.
    Conway EJ; Wen J; Feng Y; Mo A; Huang WT; Keever-Taylor CA; Hari P; Vesole DH; Chang CC
    Arch Pathol Lab Med; 2009 Oct; 133(10):1594-9. PubMed ID: 19792049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction.
    Szczepek AJ; Seeberger K; Wizniak J; Mant MJ; Belch AR; Pilarski LM
    Blood; 1998 Oct; 92(8):2844-55. PubMed ID: 9763569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
    Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
    Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes.
    Rasmussen T; Lodahl M; Hancke S; Johnsen HE
    Leuk Lymphoma; 2004 Jul; 45(7):1413-7. PubMed ID: 15359642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood B-cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements.
    Bergsagel PL; Masellis Smith A; Belch AR; Pilarski LM
    Curr Top Microbiol Immunol; 1995; 194():17-24. PubMed ID: 7534667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Thiago LS; Perez-Andres M; Balanzategui A; Sarasquete ME; Paiva B; Jara-Acevedo M; Barcena P; Sanchez ML; Almeida J; González M; San Miguel JF; Garcia-Sanz R; Orfao A
    Haematologica; 2014 Jan; 99(1):155-62. PubMed ID: 23872308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
    Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells.
    Chen BJ; Epstein J
    Blood; 1996 Mar; 87(5):1972-6. PubMed ID: 8634446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.
    LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; Gariépy J
    Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications.
    Luque R; Brieva JA; Moreno A; Manzanal A; Escribano L; Villarrubia J; Velasco JL; López-Jiménez J; Cerveró C; Otero MJ; Martínez J; Bellas C; Roldán E
    Clin Exp Immunol; 1998 Jun; 112(3):410-8. PubMed ID: 9649209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma.
    Trepel M; Martens V; Doll C; Rahlff J; Gösch B; Loges S; Binder M
    PLoS One; 2012; 7(2):e31998. PubMed ID: 22384124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone.
    Reiman T; Seeberger K; Taylor BJ; Szczepek AJ; Hanson J; Mant MJ; Coupland RW; Belch AR; Pilarski LM
    Blood; 2001 Nov; 98(9):2791-9. PubMed ID: 11675353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM; Belch AR
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients.
    Hosen N; Matsuoka Y; Kishida S; Nakata J; Mizutani Y; Hasegawa K; Mugitani A; Ichihara H; Aoyama Y; Nishida S; Tsuboi A; Fujiki F; Tatsumi N; Nakajima H; Hino M; Kimura T; Yata K; Abe M; Oka Y; Oji Y; Kumanogoh A; Sugiyama H
    Leukemia; 2012 Sep; 26(9):2135-41. PubMed ID: 22430638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements.
    Szczepek AJ; Bergsagel PL; Axelsson L; Brown CB; Belch AR; Pilarski LM
    Blood; 1997 Mar; 89(5):1824-33. PubMed ID: 9057669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.
    Rawstron AC; Davies FE; Owen RG; English A; Pratt G; Child JA; Jack AS; Morgan GJ
    Br J Haematol; 1998 Jan; 100(1):176-83. PubMed ID: 9450807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.
    McSweeney PA; Wells DA; Shults KE; Nash RA; Bensinger WI; Buckner CD; Loken MR
    Blood; 1996 Jul; 88(2):622-32. PubMed ID: 8695810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
    Lemoli RM; Fortuna A; Motta MR; Rizzi S; Giudice V; Nannetti A; Martinelli G; Cavo M; Amabile M; Mangianti S; Fogli M; Conte R; Tura S
    Blood; 1996 Feb; 87(4):1625-34. PubMed ID: 8608257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.